InsidersTradesSigma
Browse the full record of transactions filed by Chambers Michael Andrew, Director. Director active across 1 companies, notably Sarepta Therapeutics, Inc.. Cumulatively, 1 disclosures have been logged. The latest transaction was disclosed on 2 June 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration
Michael Andrew Chambers is a Board Member at Sarepta Therapeutics, Inc., a biopharmaceutical company focused on developing treatments for rare diseases. As a board member, he participates in overseeing the company's strategies and making key decisions. Michael brings expertise in biopharmacy and product development.